{"product_id":"orasure-marketing-mix","title":"OraSure Technologies Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOraSure Technologies blends diagnostic innovation with targeted pricing and channel strategies to serve healthcare providers and consumers; this snapshot reveals product strengths, distribution reach, and promotional focus but only scratches the surface.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfectious Disease Point-of-Care Diagnostics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure’s infectious disease point-of-care diagnostics deliver minutes-long results for HIV and Hepatitis C using proprietary oral-fluid tests, avoiding blood draws and improving patient comfort; oral-fluid devices accounted for ~28% of OraSure’s $224M 2024 revenue. As of late 2025, the portfolio added integrated digital reporting for real-time public-health tracking, enabling automated case reporting to health agencies. These low-cost, portable tools cost clinics about $8–$12 per test and remain central to decentralized care and outreach programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMolecular Specimen Collection and Stabilization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure Technologies, via subsidiary brands, sells advanced DNA, RNA, and microbiome collection kits that stabilize samples at ambient temperature, eliminating cold chain costs and preserving genomic integrity for transport; labs report up to 98% RNA integrity retention over 7 days. Researchers and clinicians use these kits for genetic testing and personalized medicine; by end-2025 the line supports high-throughput automated workflows, boosting sample throughput by ~3x and reducing per-sample handling costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOver-the-Counter Diagnostic Kits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOraSure’s OraQuick at-home kits give consumers private, convenient testing for HIV and respiratory illnesses, driving retail revenue that contributed to OraSure Technologies’ $212M product sales in 2024; 2025 updates aim to boost market share further.\u003c\/p\u003e\n\u003cp\u003eThe kits prioritize simple design and clear instructions to maximize layperson accuracy; independent studies report OraQuick HIV sensitivity ~92% and specificity ~99% in self-administered settings.\u003c\/p\u003e\n\u003cp\u003e2025 strategic changes extended shelf-life by 18 months and broadened distribution to major US pharmacy chains, improving retail availability and lowering stockouts by an estimated 30%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSubstance Abuse Testing Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOraSure Technologies offers a product mix of oral fluid-based substance abuse tests for workplace, forensic, and judicial use, combining rapid point-of-collection devices and laboratory confirmatory assays.\u003c\/p\u003e\n\u003cp\u003eOral fluid sampling provides non-invasive, tamper-resistant alternatives to urinalysis; OraSure reported ~20% segment revenue growth in 2024, driven by employer drug-screening demand.\u003c\/p\u003e\n\u003cp\u003eTests meet diverse regulatory standards (SAMHSA, DOT, ISO) and support faster turnaround, reducing detection-to-action time by days versus urine methods.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOral fluid = non-invasive, tamper-resistant\u003c\/li\u003e\n\u003cli\u003eRapid devices + lab confirms\u003c\/li\u003e\n\u003cli\u003e~20% 2024 segment revenue growth\u003c\/li\u003e\n\u003cli\u003eMeets SAMHSA\/DOT\/ISO standards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMicrobiome and Genomic Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOraSure Technologies offers end-to-end microbiome and genomic services—sample collection, sequencing, and bioinformatics reporting—for academic and commercial partners, extending value beyond its diagnostic hardware.\u003c\/p\u003e\n\u003cp\u003eThese services convert raw biological data into actionable insights for health and nutrition; in 2025 they increasingly embed AI-driven analytics, cutting analysis time by ~30% and improving variant calling accuracy by ~5% in partner pilots.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnd-to-end: collection to bioinformatics\u003c\/li\u003e\n\u003cli\u003eClients: academic \u0026amp; commercial partners\u003c\/li\u003e\n\u003cli\u003eValue: adds insights to hardware\u003c\/li\u003e\n\u003cli\u003e2025: AI integration, ~30% faster analysis\u003c\/li\u003e\n\u003cli\u003eImpact: aids discovery in health \u0026amp; nutrition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOraSure: Retail-led revenue, 20% substance-use growth, AI speeds genomics 30%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOraSure’s product mix centers on oral-fluid POC diagnostics, at-home OraQuick kits, substance‑use oral tests, and genomic\/microbiome collection + analytics; oral-fluid tests drove ~28% of $224M 2024 revenue, substance‑use grew ~20% in 2024, retail product sales were $212M in 2024, and AI-enabled services cut analysis time ~30% in 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOral-fluid POC\u003c\/td\u003e\n\u003ctd\u003e~28% of $224M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOraQuick retail\u003c\/td\u003e\n\u003ctd\u003e$212M product sales (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubstance‑use\u003c\/td\u003e\n\u003ctd\u003e~20% growth (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenomics services\u003c\/td\u003e\n\u003ctd\u003e~30% faster (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into OraSure Technologies’ Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context for practical benchmarking.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses OraSure Technologies’ 4P marketing insights into a concise, at-a-glance view to quickly communicate product positioning, pricing strategy, promotional tactics, and placement opportunities for leadership and cross-functional teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer E-commerce Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure sells direct through its own sites and Amazon, driving DTC growth—online sales accounted for about 28% of consumer revenue in 2024, per company filings.\u003c\/p\u003e\n\u003cp\u003eFor OTC tests, privacy and convenience are key; discrete packaging and same‑day or 1–2 day shipping cover 95% of US ZIP codes, cutting purchase friction.\u003c\/p\u003e\n\u003cp\u003eDigital channels enable direct user engagement and first‑party data capture, improving repeat purchase rates by roughly 12% year over year and boosting margin vs retail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail Pharmacy and Big-Box Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePhysical availability in CVS, Walgreens, and Walmart gives OraSure diagnostic products broad public access; in 2024 these chains represented over 40% of U.S. retail pharmacy sales, boosting impulse and planned purchases.\u003c\/p\u003e\n\u003cp\u003eThese partnerships let OraSure tap established foot traffic and brand trust, supporting repeat purchases and Medicare-linked sales channels.\u003c\/p\u003e\n\u003cp\u003eOraSure runs a sophisticated supply chain across thousands of retail points, using demand forecasting to cut stockouts—retail OOS rates fell toward industry average ~8% in 2024.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the company targets maximizing shelf space and premium diagnostic-aisle placement, aiming for a 15–20% increase in facings versus 2023 baseline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Health and Governmental Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eA large share of OraSure Technologies’ distribution runs through contracts with state health departments, the US CDC, and international NGOs, supplying point-of-care infectious disease tests for mass screening. These channels enabled delivery of over 1.2 million rapid test units in 2024 to high-risk and low-infrastructure regions. Long-term procurement agreements create steady, predictable demand and support scale-up for outbreak response and surveillance programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical and Academic Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOraSure sells molecular collection products directly to labs, universities, and biotech firms worldwide, using a technical B2B sales force focused on genomic research needs.\u003c\/p\u003e\n\u003cp\u003eAs of 2025 OraSure’s research channel drives \u0026gt;20% of molecular product revenue, with a global distributor network covering 50+ countries to reach major research hubs and emerging markets.\u003c\/p\u003e\n\u003cp\u003eThe company positions its stabilization tech as the standard for large-scale population studies and clinical trials, cited in dozens of peer-reviewed studies and used in NIH-funded cohorts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDirect B2B sales to labs, universities, biotech\u003c\/li\u003e\n\u003cli\u003eSpecialized sales force for genomic research\u003c\/li\u003e\n\u003cli\u003e50+ countries via global distributors\u003c\/li\u003e\n\u003cli\u003eDrives \u0026gt;20% of molecular product revenue (2025)\u003c\/li\u003e\n\u003cli\u003eUsed in NIH-funded cohorts and multiple peer-reviewed studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distributor Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOraSure maintains global reach by partnering with regional distributors who navigate local regulation, importation, logistics, and sales support outside North America, cutting fixed costs of direct offices.\u003c\/p\u003e\n\u003cp\u003eIn 2025 the company is prioritizing Asia and Latin America expansion via distributor alliances; distributors enabled ~40% of international revenue in 2024, and targeting 10–15% regional revenue growth in 2025.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDistributors handle compliance, imports, logistics\u003c\/li\u003e\n\u003cli\u003eReduce overhead vs direct presence\u003c\/li\u003e\n\u003cli\u003e~40% international revenue via partners (2024)\u003c\/li\u003e\n\u003cli\u003e2025 goal: 10–15% growth in Asia\/LatAm\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOraSure: Diversified channels — DTC 28%, retail \u0026gt;40%, intl \u0026amp; gov growth drivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOraSure mixes DTC (28% consumer online sales in 2024) with broad retail (CVS\/Walgreens\/Walmart \u0026gt;40% pharmacy sales) and B2B\/government contracts (1.2M rapid tests in 2024); distributors drive ~40% international revenue (2024) and research channel \u0026gt;20% molecular revenue (2025 target).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003e2024\/25 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOnline DTC\u003c\/td\u003e\n\u003ctd\u003e28% consumer sales (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\u003c\/td\u003e\n\u003ctd\u003eChains \u0026gt;40% pharmacy sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGov\/NGO\u003c\/td\u003e\n\u003ctd\u003e1.2M tests (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl distributors\u003c\/td\u003e\n\u003ctd\u003e~40% intl revenue (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;20% molecular revenue (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eOraSure Technologies 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual OraSure Technologies 4P's Marketing Mix document you’ll receive instantly after purchase—no surprises; it’s the exact, fully complete analysis ready for immediate use, editable and high-quality.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750247772537,"sku":"orasure-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/orasure-marketing-mix.png?v=1772223520","url":"https:\/\/matrixbcg.com\/products\/orasure-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}